TreeFrog Therapeutics Funding: $83M Raised, Series B (2022)
TreeFrog Therapeutics is based in Lyon, France. It has raised $83M in total funding. Latest round: Series B.
TreeFrog Therapeutics funding overview
TreeFrog Therapeutics is based in Lyon, France. TreeFrog Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for TreeFrog Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Bpifrance Large Venture, Leonard Green & Partners, Bristol-Myers Squibb, XAnge. 4 distinct backers are named across the disclosed rounds.
TreeFrog Therapeutics at a glance
Total raised
$83M
Latest round
Series B
Latest round date
January 2022
Headquarters
Lyon, France
Notable investors
Bpifrance Large Venture, Leonard Green & Partners, Bristol-Myers Squibb, XAnge
Frequently asked about TreeFrog Therapeutics funding
How much has TreeFrog Therapeutics raised?
TreeFrog Therapeutics has raised $83M in total disclosed funding across the rounds on record.
Who has invested in TreeFrog Therapeutics?
Bpifrance Large Venture, Leonard Green & Partners, Bristol-Myers Squibb, XAnge are named among the investors backing TreeFrog Therapeutics.
What was the latest TreeFrog Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2022.
Where is TreeFrog Therapeutics based?
TreeFrog Therapeutics is based in Lyon, France.
When did TreeFrog Therapeutics last raise?
The last disclosed TreeFrog Therapeutics round closed in January 2022 at Series B.
Every TreeFrog Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Lyon at a similar stage.
